UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis

Annals of the rheumatic diseases, 2007-07, Vol.66 (7), p.945-951

2007

Volltextzugriff (PDF)

Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis

Annals of the rheumatic diseases, 2005-11, Vol.64 (11), p.1563-1567

2005

Volltextzugriff (PDF)

A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis

Osteoarthritis and cartilage, 2007-12, Vol.15 (12), p.1348-1356

2007

Volltextzugriff (PDF)

The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle

Journal of Virology, 1996-12, Vol.70 (12), p.8645-8652

1996

Volltextzugriff (PDF)

Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity

Journal of Virology, 1995-02, Vol.69 (2), p.642-650

1995

Volltextzugriff (PDF)

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis

Current medical research and opinion, 2005-05, Vol.21 (5), p.715-722

2005

Volltextzugriff (PDF)

Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration

Journal of Virology, 1995-09, Vol.69 (9), p.5904-5907

1995

Volltextzugriff (PDF)

Evaluation of the Comparative Efficacy of Etoricoxib and Ibuprofen for Treatment of Patients With Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial

Mayo Clinic proceedings, 2005-04, Vol.80 (4), p.470-479

2005

Volltextzugriff (PDF)

Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials

Clinical therapeutics, 2004, Vol.26 (1), p.70-83

2004

Volltextzugriff (PDF)

Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]

BMC musculoskeletal disorders, 2005-12, Vol.6 (1), p.58-58, Article 58

2005

Volltextzugriff (PDF)

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

The Lancet (British edition), 2013-08, Vol.382 (9894), p.769-779

BAIGENT, Colin

2013

Volltextzugriff (PDF)

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

The Lancet (British edition), 2006-11, Vol.368 (9549), p.1771-1781

2006

Volltextzugriff (PDF)

Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with Rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs ( Ibuprofen, Diclofenac, and Nabumetone)

The American journal of cardiology, 2002-01, Vol.89 (2), p.204-209

2002

Volltextzugriff (PDF)

The Morphology of the Immature HIV-1 Virion

Virology (New York, N.Y.), 1997-02, Vol.228 (1), p.112-114

1997

Volltextzugriff (PDF)

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty‐two–week, randomized, controlled study

Arthritis and rheumatism, 2005-04, Vol.52 (4), p.1205-1215

2005

Volltextzugriff (PDF)

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy

Blood, 2006-03, Vol.107 (5), p.1785-1790

2006

Volltextzugriff (PDF)

Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery : A randomized, double-blind, placebo-controlled study

Anesthesia and analgesia, 2005-10, Vol.101 (4), p.1104-1111

2005

Volltextzugriff (PDF)

The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis

Current medical research and opinion, 2004-10, Vol.20 (10), p.1539-1548

2004

Volltextzugriff (PDF)

Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension

Journal of rheumatology, 2006-05, Vol.33 (5), p.985

2006

Volltextzugriff (PDF)

Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX‐2 selective Inhibitor etoricoxib

Current medical research and opinion, 2006-12, Vol.22 (12), p.2365-2374

2006

Volltextzugriff (PDF)

Evaluation of the effect of perioperative rofecoxib treatment on pain control and clinical outcomes in patients recovering from gynecologic abdominal surgery: a randomized, double-blind, placebo-controlled clinical study

Regional anesthesia and pain medicine, 2006-03, Vol.31 (2), p.134-142

2006

Volltextzugriff (PDF)

Sequence Homology between Two Membrane Transport ATPases, the Kdp-ATPase of Escherichia coli and the Ca2+-ATPase of Sarcoplasmic Reticulum

Proceedings of the National Academy of Sciences - PNAS, 1984-08, Vol.81 (15), p.4746-4750

1984

Volltextzugriff (PDF)

Etoricoxib demonstrates similar efficacy and improved gastrointestinal safety compared to naproxen in two 138-week randomized studies of osteoarthritis patients

2004

Volltextzugriff (PDF)

Lung eQTLs to help reveal the molecular underpinnings of asthma

PLoS genetics, 2012-11, Vol.8 (11), p.e1003029-e1003029

2012

Volltextzugriff (PDF)

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

The New England journal of medicine, 2000-11, Vol.343 (21), p.1520-1528

2000

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(75)
Webseiten
(1)

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

Humans
(45)
Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Male
(24)
Biological And Medical Sciences
(23)
Female
(23)
Medical Sciences
(22)
Adult
(19)
Aged
(19)
Middle Aged
(19)
Double-Blind Method
(18)
Cyclooxygenase Inhibitors - Therapeutic Use
(16)
Lactones - Adverse Effects
(15)
Sulfones - Adverse Effects
(15)
Anti-Inflammatory Agents, Non-Steroidal - Adverse Effects
(14)
Cyclooxygenase Inhibitors - Adverse Effects
(13)
Sulfones - Therapeutic Use
(13)
General & Internal Medicine
(12)
Naproxen - Adverse Effects
(12)
Pharmacology. Drug Treatments
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis

Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis

A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis

The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle

Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis

Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration

Evaluation of the Comparative Efficacy of Etoricoxib and Ibuprofen for Treatment of Patients With Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial

Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials

Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with Rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs ( Ibuprofen, Diclofenac, and Nabumetone)

The Morphology of the Immature HIV-1 Virion

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty‐two–week, randomized, controlled study

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy

Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery : A randomized, double-blind, placebo-controlled study

The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis

Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension

Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX‐2 selective Inhibitor etoricoxib

Evaluation of the effect of perioperative rofecoxib treatment on pain control and clinical outcomes in patients recovering from gynecologic abdominal surgery: a randomized, double-blind, placebo-controlled clinical study

Sequence Homology between Two Membrane Transport ATPases, the Kdp-ATPase of Escherichia coli and the Ca2+-ATPase of Sarcoplasmic Reticulum

Etoricoxib demonstrates similar efficacy and improved gastrointestinal safety compared to naproxen in two 138-week randomized studies of osteoarthritis patients

Lung eQTLs to help reveal the molecular underpinnings of asthma

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Suchergebnisse filtern